Cargando…
Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
The mTOR inhibitor rapamycin ameliorates the clinical and biochemical phenotype of mouse, worm, and cellular models of mitochondrial disease, via an unclear mechanism. Here, we show that prolonged rapamycin treatment improved motor endurance, corrected morphological abnormalities of muscle, and incr...
Autores principales: | Civiletto, Gabriele, Dogan, Sukru Anil, Cerutti, Raffaele, Fagiolari, Gigliola, Moggio, Maurizio, Lamperti, Costanza, Benincá, Cristiane, Viscomi, Carlo, Zeviani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220341/ https://www.ncbi.nlm.nih.gov/pubmed/30309855 http://dx.doi.org/10.15252/emmm.201708799 |
Ejemplares similares
-
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
por: Viscomi, Carlo, et al.
Publicado: (2011) -
Perturbed Redox Signaling Exacerbates a Mitochondrial Myopathy
por: Dogan, Sukru Anil, et al.
Publicado: (2018) -
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
por: Civiletto, Gabriele, et al.
Publicado: (2015) -
Opa1 Overexpression Protects from Early-Onset Mpv17(−/−)-Related Mouse Kidney Disease
por: Luna-Sanchez, Marta, et al.
Publicado: (2020) -
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
por: Brunetti, Dario, et al.
Publicado: (2014)